TickerFactsScreenerDevelopers

Inhibikase Therapeutics, Inc. (IKT) — Revenue

Annual figures by fiscal year, from SEC filings.

2020: $698.5K2021: $3.10M2022: $123.4K2023: $260.5K2024: $0$0
2020Revenue (USD)2024
Fiscal YearRevenueChange YoY
2024$0-100.0%
2023$260.5K+111.0%
2022$123.4K-96.0%
2021$3.10M+343.9%
2020$698.5K—